Biogen (BIIB) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.49 | 2.65 | 2.65 | 1.42 | 1.01 | 0.82 | |||
| Changes by years, y/y, % | -50% | +444% | 0% | -46% | -29% | +2.1% | |||
Biogen. Debt/EBITDA
Biogen. Debt/EBITDA, changes, %
Biogen (BIIB) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.24 | 1.13 | 0.75 | 1.01 | 0.82 | 0.82 | ||
| Changes by years, y/y, % | -47% | -34% | -53% | -25% | -34% | |||
| Changes by quarters, q/q, % | -8% | -9% | -34% | +34% | -19% | |||